Wall Street
Price Targets

6LUA Price Targets Summary
Novan Inc

There are no price targets for 6LUA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Novan Inc Competitors:
Price Targets
SLGL
Sol Gel Technologies Ltd
21% Upside
MEGA
Mega Lifesciences PCL
8% Upside
4523
Eisai Co Ltd
9% Upside
000739
Apeloa Pharmaceutical Co Ltd
16% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
31% Upside
170900
Dong-A ST Co Ltd
24% Upside
234080
JW Life Science Corp
35% Upside
SNDL
Sundial Growers Inc
219% Upside

Revenue
Forecast

Revenue Estimate
Novan Inc

For the last 8 years the compound annual growth rate for Novan Inc's revenue is 96%. The projected CAGR for the next 2 years is 77%.

96%
Past Growth
77%
Estimated Growth
Estimates Accuracy
7%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Novan Inc

Operating Income forecast
is not available for
Novan Inc

Net Income
Forecast

Net Income Estimate
Novan Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 6LUA's stock price target?
Not Available

6LUA doesn't have any price targets made by Wall Street professionals.

What is Novan Inc's Revenue forecast?
Projected CAGR
77%

For the last 8 years the compound annual growth rate for Novan Inc's revenue is 96%. The projected CAGR for the next 2 years is 77%.

Back to Top